STAT+: DOJ’s swift win in OhioHealth case should have hospitals studying their contracts, experts say
The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
Read full article →Latest Healthcare Policy news from across the web.
The speed of DOJ's proposed antitrust settlement with OhioHealth should put other hospitals on notice, experts say.
Read full article →The FTC and four state attorneys general have sued the main professional organization for gender-affirming care clinicians.
Read full article →A new study found that two diversity-oriented programs supported by the NIH doubled the odds that an undergraduate would earn a Ph.D.
Read full article →Luigi Mangione plans to assert a psychiatric defense at his state murder trial, claiming he was suffering from extreme emotional disturbance when he gunned down UnitedHealthcare CEO Brian Thompson.
Read full article →More than 60 organizations are urging the FDA to withdraw approval for what they called the “unsafe” use of antibiotics for preventing disease in food-producing livestock.
Read full article →UniQure will submit Huntington's therapy for approval, Eli Lilly buys 4E Therapeutics, and more biotech news
Read full article →A cyber extortion group claimed to have stolen more than a terabyte of data from Novo Nordisk and said it is exploring selling some of the data
Read full article →In this edition of AI Prognosis, Brittany Trang takes a close look at ambient scribe developer Abridge's claim about being patient-centered.
Read full article →Infant mortality rate dips, OTC naloxone options rise, and other health news from Morning Rounds
Read full article →The FDA has reversed its opposition to a closely watched experimental treatment for Huntington’s disease, clearing a path for its maker.
Read full article →In Pakistan, taxes on menstrual products can add up. Activists have long worked to change this. Now a new budget wipes out the 18% sales tax. But questions remain about the impact on prices.
Read full article →Should the federal government try to slow — or even block — U.S. biotech deals that could benefit China?
Read full article →